NCT02941796View on ClinicalTrials.gov

Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions
Hyperlipidemias
Interventions
DRUG

HCP1105

DRUG

HCP0918

DRUG

HCP0816

Trial Locations (1)

Unknown

Inje University Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02941796 - Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter